Skip to main content

Fulgent Genetics, Inc.

corporate_fare Company Profile

Fulgent Genetics, Inc.

Exchange: NASDAQSector: Industrial Applications And Services

show_chartPrice Chart

Loading chart...

feed FLGT - Latest Insights

FLGT
Mar 31, 2026, 4:55 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
CEO Ming Hsieh Discloses Over 76% of His Fulgent Genetics Stake is Pledged
Sentiment: Negative
View Wiseek Article
FLGT
Mar 31, 2026, 4:13 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Fulgent Genetics Schedules Annual Meeting, Proposes New 2026 Equity Incentive Plan
Sentiment: Neutral
View Wiseek Article
FLGT
Mar 17, 2026, 4:36 PM EDT
Filing Type: 8-K
Importance Score:
8
Fulgent Genetics Finalizes $56.9M Acquisition of Bako Diagnostics and StrataDx
Sentiment: Neutral
View Wiseek Article
FLGT
Mar 11, 2026, 5:24 PM EDT
Filing Type: 4
Importance Score:
8
CEO's Trust Pays $10.7M to Cancel Forward Sale Contract, Unpledging 750K Shares
Sentiment: Positive
View Wiseek Article
FLGT
Feb 27, 2026, 7:15 AM EST
Filing Type: 10-K
Importance Score:
8
Fulgent Genetics Reports Widened Losses, Negative Operating Cash Flow, and Anticipates Significant 2026 Revenue Decline from Key Customer
Sentiment: Negative
View Wiseek Article
FLGT
Feb 27, 2026, 7:13 AM EST
Source: Reuters
Importance Score:
8
Fulgent Genetics Q4 revenue misses; forecasts about $350 mln in 2026 revenue
Sentiment: Negative
View Wiseek Article
FLGT
Feb 27, 2026, 7:04 AM EST
Filing Type: 8-K
Importance Score:
8
Fulgent Genetics Projects Significant 2026 Non-GAAP Loss Due to Major Customer Departure
Sentiment: Negative
View Wiseek Article
FLGT
Feb 27, 2026, 7:00 AM EST
Source: Reuters
Importance Score:
8
BRIEF-Fulgent Genetics Q4 Revenue USD 83.336 Million
Sentiment: Negative
View Wiseek Article